The Society for Immunotherapy of Cancer (SITC) is pleased to announce the recipients of the 2022 Annual Awards! Please join us in celebrating these individuals who have notably contributed to the cancer immunotherapy field. The 2022 award recipients will be honored throughout the 37th Annual Meeting & Pre-Conference Programs, Nov. 8–12, 2022 in Boston, MA.
The Forward Fund provides grants that will help attract the brightest young minds in cancer and/or immunology research to the cancer immunotherapy domain. It informs those outside of the cancer immunotherapy field about the huge promise of this modality, which offers the potential of creating long-term remissions and/or prolongation of survival for people suffering from an expanding array of advanced cancer types. The Forward Fund also educates established clinical oncologists regarding the application and potential benefits of this treatment modality. The Forward Fund is proud to financially support the Richard V. Smalley Memorial Award and Lectureship, the Presidential Award and the Young Investigator Travel Awards.
The Academy of Immuno-Oncology was established by SITC to honor individuals who have launched the field of cancer immunotherapy into the breakthrough cancer treatment it is today and bring together the brightest minds in the field to continue to advance SITC, the field, and the next generation of immuno-oncologists.
In memory of past SITC president and charter member Dr. Richard V. Smalley, SITC is proud to present the annual Richard V. Smalley Memorial Award and Lectureship each year to a recognizable clinician/scientist and luminary in the field that has significantly contributed to the advancement of cancer immunotherapy research.Established in 2005, the award serves to honor those that have been pioneers in their work and made a notable impact worthy of high regard and recognition by their peers. As a part of the award, the honoree serves as a primary keynote presenter at the Annual Meeting, giving a 45-minute lecture on his/her research and the award is accompanied by an honorarium of $5,000.
SITC's Anniversary Awards celebrate the achievements of current and future leaders in the cancer immunotherapy field. The work of these dedicated individuals that include young investigators, luminaries, leading organizations, regulatory agencies and industry seeks to propel the field forward and build a solid foundation for future advances and soon, a cure.
In 2021, SITC was humbled to present the inaugural SITC Medal of Honor to Uğur Şahin, MD and Özlem Türeci, MD for their efforts championing the development and distribution of the vaccine against COVID-19 using mRNA technology. SITC recognizes their incredible contributions to humanity and the countless lives saved.
In 2017, SITC recognized Sean Parker with the SITC Public Service Award, which honors an individual or group that has made substantial contributions to fostering and enhancing the field of cancer immunotherapy through increasing public understanding and awareness, research efforts, and/or funding for cancer immunotherapy.
In 2019, SITC recognized Dr. Martin “Mac” Cheever with the Distinguished Service Award for his work establishing and directing the Cancer Immunotherapy Trials Network (CITN). The CITN designs and conducts early-stage, multicenter clinical trials of promising immunotherapy agents. Without the CITN trials and Dr. Cheever’s leadership and vision, patients would not have access to these promising experimental drugs.
Each year, the Journal for ImmunoTherapy of Cancer (JITC) honors several of its top authors from the past year with an award at the SITC Annual Meeting.The JITC Best Paper Awards celebrate excellence in scientific research and are awarded to researchers demonstrating leadership in the field as well as innovation and high-quality execution and discussion in their manuscripts.
The SITC Steven A. Rosenberg, MD, PhD, Scholars Award was established in honor of Dr. Rosenberg. This award recognizes his many contributions to the field by supporting investigators, who are emerging leaders in immuno-oncology, focused on a novel approach to advancing the field of cancer immunotherapy.
To promote growth and achievement amongst young investigators in the field of cancer biologics and to recognize excellence in SITC Annual Meeting oral abstract and poster presentations, SITC offers the following "Young Investigator Awards:Created in 2007, the SITC Abstract Travel Award highlights promising young investigators who submitted high-scoring abstracts to the SITC Annual Meeting, based on the quality of their research and potential to advance the field. The SITC Presidential Travel Award is given to the top four abstracts submitted in any category and authored by young investigators who are selected for oral presentation during the Presidential Session of the SITC Annual Meeting.
Established in 1991, the SITC Presidential Award is the most prestigious Young Investigator Award recognizing the young investigator deemed to have the most outstanding oral abstract presentation among those delivered in the Presidential Session of the SITC Annual Meeting.
Elizabeth Stirling, PhD candidate, of Wake Forest University, accepts the 2019 SITC Presidential Award from SITC President Mario Sznol, MD.
Launched in November 2015, the Connect-a-Colleague campaign is designed to encourage members to personally reach out and invite potential members to join the society. An online tool was created for members to refer multiple potential members at a time. New members are also encouraged to indicate SITC members who referred them for membership.
To promote growth and achievement amongst early career investigators in advancing their cancer immunotherapy research by leveraging spatial technology platforms, SITC offers annual SITC Technology Awards
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org